POONAM GOSWAMI: Open Payments
NPI 1114357142 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,839 in 17 payments from 13 companies in 2025. Trend: 2023 $969 · 2024 $1,067 · 2025 $1,839
Food & beverage: $1,839
| Company | Payments | Amount |
|---|---|---|
| PharmaEssentia USA Corporation | 2 | $275 |
| Gilead Sciences, Inc. | 3 | $230 |
| Corcept Therapeutics | 2 | $206 |
| Abbott Laboratories | 1 | $146 |
| JAZZ PHARMACEUTICALS INC. | 1 | $144 |
| Amgen Inc. | 1 | $138 |
| SOBI, INC | 1 | $126 |
| ABIOMED | 1 | $126 |
| Axsome Therapeutics, Inc. | 1 | $117 |
| Xeris Pharmaceuticals, Inc. | 1 | $107 |
Products named: BESREMI, Korlym, Epclusa, PROCLAIM, ZIIHERA, Vonjo, Auvelity, RECORLEV.
Industry payments across TX — which companies pay providers there.
